{"podcast":{"title":"Invest Like the Best with Patrick O'Shaughnessy","slug":"invest-like-the-best","podcast_index_feed_id":982387,"rss_url":"https://feeds.megaphone.fm/CLS2859450455","website_url":"https://colossus.com/","image_url":"https://megaphone.imgix.net/podcasts/ef669774-cccd-11ed-889b-c36caad6646f/image/158efdddfb983d2678b3530d484e8aa2.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"Colossus","episode_count":577,"summary":"Conversations with the best investors and business leaders in the world. We explore their ideas, methods, and stories to help you better invest your time and money. Hear stock market and boardroom insights you can't find anywhere else. If you're a professional investor, CEO, entrepreneur, or business strategist, this is for you. Explore all our episodes and learn more at https://www.colossus.com","last_synced_at":null,"page_url":"https://stenobird.com/podcast/invest-like-the-best"},"episode":{"title":"Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.467]","slug":"alex-karnal-the-trillion-dollar-health-revolution-invest-like-the-best-ep-467","published_at":"2026-04-21T08:00:00+00:00","page_url":"https://stenobird.com/podcast/invest-like-the-best/alex-karnal-the-trillion-dollar-health-revolution-invest-like-the-best-ep-467","show_page_url":"https://stenobird.com/podcast/invest-like-the-best","url":"https://colossus.com/episode/trillion-dollar-health-revolution/","audio_url":"https://traffic.megaphone.fm/CLS4367259219.mp3?updated=1776741147","summary":"The future of medicine lies in a proactive 'health stack' designed to prevent chronic disease rather than just treating it. Alex Karnal explores how GLP-1s and PCSK9 inhibitors are shifting the paradigm from reactive care to long-term biological optimization.","meta_description":"Explore the trillion-dollar health revolution: how GLP-1s, PCSK9 inhibitors, and agentic AI are transforming drug discovery and preventative medicine.","key_points":["Main idea: The 'health stack' approach focuses on preventing the three primary killers—cardiovascular, neurocognitive, and inflammatory diseases—through early intervention","Practical takeaway: GLP-1 medicines serve as the first commercial proof that patients are willing to adopt proactive, preventative pharmaceutical strategies","Failure mode: Cancer remains the most difficult challenge because its ability to mutate and redirect pathways can render effective treatments obsolete","Technological shift: The next frontier of drug discovery requires agentic, robotically-driven systems to overcome the throughput limits of human-led experimentation","Investment insight: High-quality diagnostics must be evaluated based on both sensitivity and specificity to enable effective early-stage intervention"],"chapters":[{"start_ms":490000,"title":"The Fundamentals of Lipid Optimization","summary":"An exploration of cardiometabolic health and the role of LDL cholesterol in long-term disease prevention."},{"start_ms":930000,"title":"The Economics of Drug Sales","summary":"The high capital intensity of traditional pharmaceutical marketing and the reliance on massive sales forces."},{"start_ms":1370000,"title":"GLP-1s and the Proactive Patient","summary":"How GLP-1 hormones act as a biological trigger for metabolic health and signal a shift in patient behavior."},{"start_ms":2220000,"title":"The Potential of PCSK9 Inhibitors","summary":"Analyzing the genetic advantages of PCSK9 mutations and why this drug class may surpass statins in importance."},{"start_ms":3060000,"title":"Evaluating Diagnostic Accuracy","summary":"The critical importance of sensitivity and specificity metrics when assessing new medical testing technologies."},{"start_ms":3910000,"title":"AI and the Future of Drug Discovery","summary":"How agentic AI and robotic systems can unlock unprecedented scale in the scientific method and biological experimentation."},{"start_ms":5170000,"title":"Personal Motivation and Purpose","summary":"A reflection on the transition from pure profit-seeking to finding meaningful impact in life sciences."}],"topics":["Life Sciences","Drug Discovery","GLP-1","Biotechnology","Preventative Medicine","Artificial Intelligence","Cardiovascular Health","Biotech Investing"],"duration_seconds":5540,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/invest-like-the-best/episodes/alex-karnal-the-trillion-dollar-health-revolution-invest-like-the-best-ep-467/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/invest-like-the-best/alex-karnal-the-trillion-dollar-health-revolution-invest-like-the-best-ep-467.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}